<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Trop Med Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Trop Med Infect Dis</journal-id><journal-id journal-id-type="publisher-id">tropicalmed</journal-id><journal-title-group><journal-title>Tropical Medicine and Infectious Disease</journal-title></journal-title-group><issn pub-type="epub">2414-6366</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998047</article-id><article-id pub-id-type="pmc">PMC11860599</article-id>
<article-id pub-id-type="doi">10.3390/tropicalmed10020043</article-id><article-id pub-id-type="publisher-id">tropicalmed-10-00043</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of WHO Measles Eradication Programme for the European Region of 53 Countries with Emphasis on Poland in the Years 2003&#x02013;2014</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mucha</surname><given-names>Dominika</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-tropicalmed-10-00043" ref-type="aff">1</xref><xref rid="c1-tropicalmed-10-00043" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4088-3541</contrib-id><name><surname>&#x00141;ubkowska</surname><given-names>Beata</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-tropicalmed-10-00043" ref-type="aff">1</xref><xref rid="af2-tropicalmed-10-00043" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6542-3002</contrib-id><name><surname>Je&#x0017c;ewska-Fr&#x00105;ckowiak</surname><given-names>Joanna</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-tropicalmed-10-00043" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1345-3271</contrib-id><name><surname>Skowron</surname><given-names>Piotr M.</given-names></name><xref rid="af2-tropicalmed-10-00043" ref-type="aff">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Tsioutis</surname><given-names>Constantinos</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Karageorgos</surname><given-names>Spyridon</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Mutters</surname><given-names>Nico</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Palos</surname><given-names>Carlos</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-tropicalmed-10-00043"><label>1</label>Department of Health and Natural Sciences, Division of Biochemistry, Gdansk University of Physical Education and Sport, 80-308 Gdansk, Poland; <email>beata.lubkowska@awf.gda.pl</email></aff><aff id="af2-tropicalmed-10-00043"><label>2</label>Department of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland; <email>j.jezewska-frackowiak@ug.edu.pl</email> (J.J.-F.); <email>piotr.skowron@ug.edu.pl</email> (P.M.S.)</aff><author-notes><corresp id="c1-tropicalmed-10-00043"><label>*</label>Correspondence: <email>dominika.mucha@awf.gda.pl</email>; Tel.: +48-585547180</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>43</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>27</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background: The vaccination programmes after the 2nd World War and the application of safe and effective vaccines were expected to eliminate infectious diseases within the World Health Organization (WHO) European Region. However, epidemiological indexes show isolated cases and local epidemiology outbreaks of viral measles, that draw attention to re-evaluate the effectiveness and obstacles of infectious disease eradication programmes. Methodology: This study analyses the available Polish governmental epidemiological data concerning the WHO European Region for the years 2003&#x02013;2014 and evaluates the effectiveness of the WHO Measles Eradication Programme implementation, since 2001. Most of these epidemiological data are either available in Polish or scattered in governmental reports only. Thus, we have compiled selected available data to present an overview focusing on Poland&#x02019;s measles epidemiological situation. Results: The analysis of the available data clearly shows that infection cases of measles are on the rise in the European Region or are steady at a relatively high level depending on the country. The critical factors to prevent measles are maintaining a vaccination level at a minimum of 95% using two doses of MMR, adequate infection detection, rapid reporting, controlling and enforcing identification, and mass media campaigns to inform societies about the necessity of measles vaccination and the safety of using MMR. Conclusions: Besides the current SARS-CoV-2 pandemics, measles is possibly the most dominating infectious disease on the rise in the European Region, including Poland. The eradication programme modifications to increase its effectiveness are of upmost importance, as measles is one of the most infectious diseases with acute syndromes, especially affecting children.</p></abstract><kwd-group><kwd>epidemiological surveillance for measles</kwd><kwd>infectious diseases</kwd><kwd>measles</kwd><kwd>vaccine</kwd><kwd>WHO measles eradication programme</kwd><kwd>epidemiology</kwd></kwd-group><funding-group><award-group><funding-source>University of Gdansk (Poland) task</funding-source><award-id>DS 531-T040-D839-24</award-id></award-group><funding-statement>This project was supported by the University of Gdansk (Poland) task fund no. DS 531-T040-D839-24.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-tropicalmed-10-00043"><title>1. Introduction</title><p>The current SARS-CoV-2 pandemic has prompted societies and governments to realisations that epidemics are not a past history of humankind. This includes not only unprecedented events in modern times (after the Second World War), including coronavirus&#x02019;s extremely rapid outbreak and high death toll, exceeding 4 mln people worldwide, but also points to a potential for novel pandemics, including those caused by pathogens thought to be either eliminated or completely marginalised. Historically, vaccine application in Europe dates back at least to the XVIII century; one of the more documented developments was the progress in smallpox vaccine production in 1796 by Edward Jenner [<xref rid="B1-tropicalmed-10-00043" ref-type="bibr">1</xref>]. Further, the vaccination concept has expanded to other human diseases as well as veterinary applications [<xref rid="B2-tropicalmed-10-00043" ref-type="bibr">2</xref>,<xref rid="B3-tropicalmed-10-00043" ref-type="bibr">3</xref>]. However, unexpectedly, despite tens of years of preventive vaccination programmes using new-generation effective vaccines in European countries, in the XXI century, on one hand, complete eradication of some infectious diseases has taken place, but on the other, many others are returning, with noted multiple infection cases or even local outbreaks. This includes one of the most infectious viral diseases&#x02014;measles. This disease, mainly affecting children, results in long-term, dangerous and life-threatening complications. The infection is passed through contact with a person who exhibits measles symptoms. The etiological factor is the measles virus, which belongs to the <italic toggle="yes">Morbilivirus</italic> genus, family <italic toggle="yes">Paramyxoviridae</italic>, whose genetic material is composed of negatively polarised single-stranded RNA [<xref rid="B4-tropicalmed-10-00043" ref-type="bibr">4</xref>]. An acute variant of the disease is observed essentially among children, with typical symptoms such as high fever, rash, gingivitis, headache, and photophobia [<xref rid="B5-tropicalmed-10-00043" ref-type="bibr">5</xref>]. Thus far, the most effective preventive method against measles is active protection, i.e., vaccination.</p><p>Since 2001, the European Region has been subjected to the Measles Eradication Programme coordinated by WHO, whose major goal is taming virus transmission and finally achieving a complete eradication in all 53 countries of the region. Despite the current problems with increasing measles cases, the disease meets the criteria for complete eradication: humans are the only reservoir of the virus, neither symptomless infections nor carriage has been observed, the environment is not contaminated with the pathogen, and effective vaccines are available [<xref rid="B4-tropicalmed-10-00043" ref-type="bibr">4</xref>]. Nevertheless, social anti-vaccination movements, which have been active for the last several years, strongly promote avoiding vaccinations and have led to many children being unprotected from infectious diseases. This general public perception is linked to a publication from 1998 by Lancet, suggesting that MMR vaccines increase the probability of developing a non-specific, intestine inflammatory syndrome and autism in vaccinated children [<xref rid="B6-tropicalmed-10-00043" ref-type="bibr">6</xref>,<xref rid="B7-tropicalmed-10-00043" ref-type="bibr">7</xref>]. The publication was later withdrawn since it was based on unproven and non-representative data. Moreover, numerous further studies have shown that there is no such link; however, the matter remains controversial, especially in mass media and general public perception [<xref rid="B6-tropicalmed-10-00043" ref-type="bibr">6</xref>].</p><p>An additional factor apparently linked to measles cases and outbreaks in the European Region is the rapid increase in human migrations across the region, from various countries, both within and from outside of Europe, including global migrations, where preventive vaccinations are either not conducted, or they are not enforced by law. In this paper, we summarise and comment on epidemiological data in the years 2003&#x02013;2014 in Poland concerning this increasingly troubling measles problem, some of which are difficult to access or in incomplete governmental reports only, and/or not available in English. We are currently continuing to collect data and preparing compilations concerning the next period, covering the years 2015&#x02013;present. Due to limited data availability from local clinics and the substantial travelling effort needed for gathering representative data, here we publish those for 2003&#x02013;2014. New data will be published as an update for 2015&#x02013;2024.</p></sec><sec id="sec2-tropicalmed-10-00043"><title>2. Materials and Methods</title><p>Based on Polish and international publication data, the progress and effectiveness of the WHO Measles Eradication Programme in the European Region, including Poland, was evaluated for a period of nine years (2003&#x02013;2014), and infection and outbreak cases were compared, as were additional, detailed factors linked to measles vaccinations.</p><sec id="sec2dot1-tropicalmed-10-00043"><title>2.1. Measles Definition</title><p>Measles is an acute and extremely infectious viral disease displaying numerous harsh syndromes, typically follicular-blemished rash, fever and at least one of the following: cough, nose rhinitis and ophthalmic [<xref rid="B8-tropicalmed-10-00043" ref-type="bibr">8</xref>]. The etiological factor is an RNA virus, classified as a <italic toggle="yes">Morbilivirus</italic> belonging to the <italic toggle="yes">Paramyxoviridae</italic> family. The only source of the measles virus is humans, with an infection route via droplets. Measles develops in four stages: incubation, prodrome periods, rash period, and recovery [<xref rid="B9-tropicalmed-10-00043" ref-type="bibr">9</xref>]. The incubation period is typically hard to detect, as it is mostly symptomless. During the heralds period high fever appears, up to 40 &#x000b0;C, along with ophthalmia, lacrimation, photophobia, catarrh of nasal mucous membranes, and dry cough. In the oral cavity, mucous membranes develop small white spots on a red background, known also as Fi&#x00142;atow-Koplik&#x02019;s spots, separated by a mucous membrane of natural colour. This stage typically lasts 1&#x02013;3 days. Next comes the rash stage, usually 14 days from the initial exposure to the measles virus. The rash begins behind the ears and around the mouth, and then spreads to the chin, torso and limbs. Initially, the rash is lumpy and dark pink, later it changes to a brick-red colour, and it further spreads and fuses with other rashes, typically covering the majority of the skin surface, leaving tracts of white, unaffected skin. At the end of the 3rd or 4th day, the rash disappears in reverse order than it had developed, leaving greyish brown skin discolourations. The recovery period starts the moment the rash disappears; in addition, the fever decreases and the patient&#x02019;s general state noticeably improves. On the skin of the face and torso minute, furfuraceous skin flakes develop. The most frequent complications include pneumonia, bronchitis, otitis media, and laryngitis subglottic. The risk of developing neurological complications increases with the age of a sick child, over the age of 9 it is 2&#x02013;3-fold higher. These complications include measles-inflicted encephalitis, myelitis, Guillain-Barr&#x000e9; syndrome, and subacute sclerotic leucoencephalitis, which cause permanent damage to motoric and mental capabilities. Gastrointestinal tract complications include stomach and intestine inflammation, liver inflammation, and appendix inflammation, among others [<xref rid="B5-tropicalmed-10-00043" ref-type="bibr">5</xref>,<xref rid="B9-tropicalmed-10-00043" ref-type="bibr">9</xref>,<xref rid="B10-tropicalmed-10-00043" ref-type="bibr">10</xref>].</p></sec><sec id="sec2dot2-tropicalmed-10-00043"><title>2.2. Vaccination Schemes</title><p>As a result of the WHO Measles Eradication Programme for the European Region, introduced in the year 2001, until the year 2011, most of the region&#x02019;s countries (51 out of 53) had introduced trivalent vaccines against measles, mumps, and rubella (MMR). The Russian Federation has introduced MMR vaccines in selected regions, while in Tajikistan only a monovalent vaccine against measles was introduced [<xref rid="B11-tropicalmed-10-00043" ref-type="bibr">11</xref>].</p><p>According to the scheme against measles adopted in Poland, vaccinations with the trivalent MMR vaccine are conducted twice, the first time in the 13&#x02013;14th month of infant life and the second in the 10th year of life [<xref rid="B12-tropicalmed-10-00043" ref-type="bibr">12</xref>,<xref rid="B13-tropicalmed-10-00043" ref-type="bibr">13</xref>]. This type of vaccine has been used in Poland since 2004, whereas the first measles vaccinations in Poland were introduced in 1974. The former scheme included a single dose vaccination in the 2nd year of infant life using a monovalent preparation, containing an attenuated mixture of various strains of measles: Schwarz, Edmonston&#x02013;Enders, Zagreb, and Leningrad [<xref rid="B4-tropicalmed-10-00043" ref-type="bibr">4</xref>,<xref rid="B14-tropicalmed-10-00043" ref-type="bibr">14</xref>]. Since 1991, two doses have been used. Routine vaccination against measles, mumps, and rubella (MMR) was introduced in Poland in 2004 [<xref rid="B4-tropicalmed-10-00043" ref-type="bibr">4</xref>]. Presently, the most often applicable MMR in Poland are M-M-RVAXPRO<sup>&#x000ae;</sup> and PRIORIX<sup>&#x000ae;</sup> which contain measles virus Enders&#x02013;Edmonston (live, attenuated) produced in chick embryo cells, Mumps virus Jeryl Lynn strain (live, attenuated) produced in chick embryo cells, and Rubella virus Wistar RA 27/3 strain (live, attenuated) produced in WI-38 human diploid lung fibroblasts [<xref rid="B4-tropicalmed-10-00043" ref-type="bibr">4</xref>,<xref rid="B15-tropicalmed-10-00043" ref-type="bibr">15</xref>]. The vaccination against measles in Poland is obligatory.</p></sec><sec id="sec2dot3-tropicalmed-10-00043"><title>2.3. WHO Measles Eradication Programme</title><p>In 2001, the Measles Eradication Programme coordinated by WHO, concerning all 53 countries of the European Region, including Poland, was introduced. The term &#x02018;eradication&#x02019; with regard to measles is defined as follows: there are no endemic outbreaks and, in the case of virus transfer from unprotected regions, further virus transmission is not supported [<xref rid="B16-tropicalmed-10-00043" ref-type="bibr">16</xref>,<xref rid="B17-tropicalmed-10-00043" ref-type="bibr">17</xref>]. Critical conditions leading to measles eradication are (i) maintaining 95% of children vaccinated with the two doses of MMR within a given population, which results in group immunity; (ii) estimation of the remaining fraction of measles-sensitive persons within a population, as based on serological assays, detecting anti-measles IgMs, conducted on persons exhibiting measles-like symptoms; and (iii) the constant monitoring of the epidemiological situation by registering all the actual and suspected measles infection cases, followed by their laboratory confirmation or rejection by the WHO Reference Laboratory. In Poland, this function is conducted by the Department of Virology at the National Institute of Public Health&#x02014;National Institute of Hygiene (NIPH-NIH). The measles eradication strategy assumes that the number of suspected measles cases would be 1 or more per 100,000 inhabitants. This translates to a minimum of 383 cases in Poland. Another assumption is to intensify the vaccination programme within national minorities, where frequently suspected measles cases are not reported to doctors and thus, infection case statistics are often underrepresented in these groups. Because measles is highly infectious, approaching 90% upon contact of a healthy person with an infected one, reporting suspected cases is obligatory in all 53 countries of the European Region [<xref rid="B18-tropicalmed-10-00043" ref-type="bibr">18</xref>].</p></sec><sec id="sec2dot4-tropicalmed-10-00043"><title>2.4. Data Indentation, Extraction and Analysis</title><p>The data on measles cases in Poland were sourced from the annual articles &#x0201c;Odra w Polsce&#x0201d; (&#x0201c;Measles in Poland&#x0201d;) published in the &#x0201c;Przegl&#x00105;d Epidemiologiczny&#x0201d; (&#x0201c;Epidemiological Review&#x0201d;) and submitted to the Department of Epidemiology of Infectious Diseases and Surveillance at the National Institute of Public Health NIH-NRI by Provincial Sanitary and Epidemiological Stations as a part of the Statistical Research Program of Public Statistics, namely the following:<list list-type="simple"><list-item><label>(1)</label><p>Annual reports on infectious diseases, infections, and poisonings (governmental form MZ-56);</p></list-item><list-item><label>(2)</label><p>Annual reports on selected infectious diseases by age, gender, place of residence, and seasonality (governmental form MZ-57);</p></list-item><list-item><label>(3)</label><p>Annual reports on selected infectious diseases by vaccination status, gender, age, and place of residence (governmental form MZ-58);</p></list-item><list-item><label>(4)</label><p>Periodic reports on cases and suspected cases of influenza (governmental form MZ-55) for the given year.</p></list-item></list></p><p>If data from other information sources were used in a given study, this is stated in the respective cited articles [<xref rid="B16-tropicalmed-10-00043" ref-type="bibr">16</xref>,<xref rid="B17-tropicalmed-10-00043" ref-type="bibr">17</xref>,<xref rid="B19-tropicalmed-10-00043" ref-type="bibr">19</xref>,<xref rid="B20-tropicalmed-10-00043" ref-type="bibr">20</xref>,<xref rid="B21-tropicalmed-10-00043" ref-type="bibr">21</xref>,<xref rid="B22-tropicalmed-10-00043" ref-type="bibr">22</xref>,<xref rid="B23-tropicalmed-10-00043" ref-type="bibr">23</xref>,<xref rid="B24-tropicalmed-10-00043" ref-type="bibr">24</xref>,<xref rid="B25-tropicalmed-10-00043" ref-type="bibr">25</xref>,<xref rid="B26-tropicalmed-10-00043" ref-type="bibr">26</xref>,<xref rid="B27-tropicalmed-10-00043" ref-type="bibr">27</xref>,<xref rid="B28-tropicalmed-10-00043" ref-type="bibr">28</xref>,<xref rid="B29-tropicalmed-10-00043" ref-type="bibr">29</xref>].</p></sec></sec><sec sec-type="results" id="sec3-tropicalmed-10-00043"><title>3. Results and Discussion</title><p>Based on the available literature and unpublished data, compilations showing statistics concerning measles for the European Region in the years 2003&#x02013;2014 have been made, with emphasis on Poland. Data are presented in the form of graphs and tables and are further commented on.</p><sec id="sec3dot1-tropicalmed-10-00043"><title>3.1. Poland: Measles Reporting Criteria</title><p>Reporting measles within 24 h from diagnosis is a legal obligation in Poland according to the Legal Act from 5 December 2008 concerning the prevention and elimination of infections and infectious diseases [<xref rid="B19-tropicalmed-10-00043" ref-type="bibr">19</xref>]. However, statistics show that the period between a doctor&#x02019;s inspection and reporting a suspected measles case to a local sanitary&#x02014;epidemiological unit is substantially longer and takes on average 5 days [<xref rid="B16-tropicalmed-10-00043" ref-type="bibr">16</xref>]. The definitions of infectious disease cases for implemented procedures of the NIPH-NIH epidemiological supervision in Poland for measles are as follows [<xref rid="B20-tropicalmed-10-00043" ref-type="bibr">20</xref>]: (i) clinical criteria state every person exhibiting simultaneously fever and maculo-papular rash, as well as at least one of the following symptoms: cough, mucous catarrh of the nose, and conjunctivitis; (ii) laboratory criteria based on clinical samples isolated from a potentially infected person, include at least one of the following: isolation of the measles virus, detection of measles coding nucleic acid, or detection of anti-measles IgMs, specific for acute measles infection or detection of measles viral antigens in the serum or saliva, with the use of specific monoclonal antibodies during a direct immunofluorescent assay against measles. An important factor while interpreting laboratory tests includes the history of measles vaccinations. In the case of a recent vaccination, the measles antigen typing or genotyping of the virus is needed to confirm or reject the presence of wild-type measles [<xref rid="B17-tropicalmed-10-00043" ref-type="bibr">17</xref>]. Epidemiological criteria are defined as human-to-human infection transfer with several case definition variants: (a) case possible&#x02014;every person meeting clinical criteria, (b) case probable&#x02014;every person meeting both clinical and epidemiological criteria, and (c) case confirmed&#x02014;every person who has not recently been vaccinated against measles and meets both clinical and laboratory criteria. In the case of recently vaccinated persons&#x02014;everyone who turned out positive in tests for the presence of wild-type measles virus [<xref rid="B20-tropicalmed-10-00043" ref-type="bibr">20</xref>].</p></sec><sec id="sec3dot2-tropicalmed-10-00043"><title>3.2. Poland: Historical Perspective and Measles Genotype Variants Landscape</title><p>Universal measles vaccination was introduced in Poland in 1975. Initially, a single dose of the measles vaccine, named Attenuvax<sup>&#x000ae;</sup>, was administered at 13&#x02013;15 months of age. Starting in 1991, two doses of the single measles vaccine (Rouvax<sup>&#x000ae;</sup>) were given&#x02014;one at 13&#x02013;15 months of age and the second at 8 years of age. Since 2004, two doses of the combined MMR vaccine, protecting against measles, mumps, and rubella, have been administered. Initially, the MMR II vaccine was used. Currently, two formulations are available on the market: M-M-RvaxPro<sup>&#x000ae;</sup> (since 2008, previously marketed as MMR II) and Priorix<sup>&#x000ae;</sup> (available since 2002). The vaccines are administered in two doses: at 13&#x02013;14 months of age and at 10 years of age. The composition of these vaccines differs slightly in the strains of attenuated live measles viruses they contain: (i) Priorix<sup>&#x000ae;</sup>&#x02014;live attenuated measles virus (Schwarz strain) at a minimum dose of 10<sup>3</sup> CCID50 and (ii) M-M-RvaxPro<sup>&#x000ae;</sup>&#x02014;live attenuated measles virus (Enders-Edmonston strain) at a minimum dose of 1 &#x000d7; 10<sup>3</sup> CCID50. Both vaccines contain the same quantity of viral particles but differ in the strain of the measles virus used. The decrease in measles cases can be attributed to the new regulations implemented in 2004, particularly the use of the new vaccines. However, the subsequent rise in measles incidence in later years is likely linked to the growing anti-vaccination movement and the increasing percentage of unvaccinated children. An analysis of data on all mandatory vaccinations in Poland reveals a significant increase in parental refusals over the years. In 2011, approximately 4700 children were not vaccinated due to parental refusal. This number rose to about 5300 in 2012, over 7000 in 2013, and exceeded 12,000 in 2014.</p><p>In Poland before the introduction of vaccination against measles, the virus infected up to 200,000 people yearly [<xref rid="B4-tropicalmed-10-00043" ref-type="bibr">4</xref>]. As a result of introducing the vaccination, both before and during the WHO Measles Eradication Programme implementation, the epidemiological status has greatly improved, by a factor of over 1000-fold, and statistical data are depicted in <xref rid="tropicalmed-10-00043-t001" ref-type="table">Table 1</xref> and <xref rid="tropicalmed-10-00043-t002" ref-type="table">Table 2</xref> and in <xref rid="tropicalmed-10-00043-f001" ref-type="fig">Figure 1</xref> and <xref rid="tropicalmed-10-00043-f002" ref-type="fig">Figure 2</xref>. The data presented in <xref rid="tropicalmed-10-00043-t001" ref-type="table">Table 1</xref> and <xref rid="tropicalmed-10-00043-t002" ref-type="table">Table 2</xref> and <xref rid="tropicalmed-10-00043-f001" ref-type="fig">Figure 1</xref> and <xref rid="tropicalmed-10-00043-f002" ref-type="fig">Figure 2</xref> have been compiled from a series of publications [<xref rid="B16-tropicalmed-10-00043" ref-type="bibr">16</xref>,<xref rid="B17-tropicalmed-10-00043" ref-type="bibr">17</xref>,<xref rid="B21-tropicalmed-10-00043" ref-type="bibr">21</xref>,<xref rid="B22-tropicalmed-10-00043" ref-type="bibr">22</xref>,<xref rid="B23-tropicalmed-10-00043" ref-type="bibr">23</xref>,<xref rid="B24-tropicalmed-10-00043" ref-type="bibr">24</xref>,<xref rid="B25-tropicalmed-10-00043" ref-type="bibr">25</xref>,<xref rid="B26-tropicalmed-10-00043" ref-type="bibr">26</xref>,<xref rid="B27-tropicalmed-10-00043" ref-type="bibr">27</xref>,<xref rid="B28-tropicalmed-10-00043" ref-type="bibr">28</xref>,<xref rid="B29-tropicalmed-10-00043" ref-type="bibr">29</xref>,<xref rid="B30-tropicalmed-10-00043" ref-type="bibr">30</xref>,<xref rid="B31-tropicalmed-10-00043" ref-type="bibr">31</xref>,<xref rid="B32-tropicalmed-10-00043" ref-type="bibr">32</xref>,<xref rid="B33-tropicalmed-10-00043" ref-type="bibr">33</xref>,<xref rid="B34-tropicalmed-10-00043" ref-type="bibr">34</xref>].</p><p>Data provided by the Central Statistical Office (GUS) indicate that between 2003 and 2014, Poland&#x02019;s population changed only slightly, increasing from 38.19 million in 2003 to 38.478 million in 2014, with an average population of 38.303 million during this period. To ensure better comparability and account for changes in health policies, the results were standardised according to the European standard population [<xref rid="B31-tropicalmed-10-00043" ref-type="bibr">31</xref>]. Due to the lack of data divided into age groups, detailed standardised calculations were not possible. However, calculations were performed considering population size and event rates per 100,000 individuals. Event rates per 100,000 individuals show significant differences between years. For example, the lowest event rate was recorded in 2004 (0.029 per 100,000), while the highest was observed in 2006 (0.315 per 100,000). Between 2010 and 2012, a decline was evident, followed by an increase in 2013 and 2014.</p><p>They evidently show the highest sensitivity of detection of various syndromes, which might be related to measles, was obtained in 2006. This is related to an increased preventive activity of the Polish healthcare system, induced by a measles epidemic in Ukraine, where by the end of 2006 the number of registered and confirmed measles cases, inflicted by measles virus genotype variant D6, reached 30,000 [<xref rid="B35-tropicalmed-10-00043" ref-type="bibr">35</xref>,<xref rid="B36-tropicalmed-10-00043" ref-type="bibr">36</xref>]. In genetic studies of measles viruses isolated in Warsaw, small local outbreaks were caused by two genotype variants&#x02014;D4 and D5, which are not related to the ones that caused the Ukraine epidemic. However, three persons residing in Ukraine during the D6 epidemic outbreak had developed measles symptoms after returning to Poland. This is an indication of a more general trend in the countries in the European Region, which have a complex genotype pattern, due to frequent reintroduced by importation and spread through highly mobile, unvaccinated groups, frequently of common ethnic origin [<xref rid="B27-tropicalmed-10-00043" ref-type="bibr">27</xref>,<xref rid="B37-tropicalmed-10-00043" ref-type="bibr">37</xref>,<xref rid="B38-tropicalmed-10-00043" ref-type="bibr">38</xref>,<xref rid="B39-tropicalmed-10-00043" ref-type="bibr">39</xref>]. However, it is also important to note, that the measles virus possesses stable antigenic architecture and all its strains belong to the same serotype. Thus, those closely related strains&#x02019; differentiation is based on genetic differences. Thus far, 8 strain groups were differentiated (A&#x02013;H), which include 23 genotypes [<xref rid="B35-tropicalmed-10-00043" ref-type="bibr">35</xref>,<xref rid="B36-tropicalmed-10-00043" ref-type="bibr">36</xref>]. Sequence analysis of the 3&#x02032; nucleoprotein gene, coding for the C-terminus of the protein has been established as a marker region for the classification of clinical isolates as a particular measles strain. Some of the genotypes (B1, E, F, G1, D1) are denoted as a &#x02018;non-active&#x02019; state, which is defined as a lack of isolation of a given strain for 15 years. All measles virus strains used for vaccine production generally belong to genotype A. However, in Europe strains belonging to genotypes D4, D5, and D6 have been observed in major part [<xref rid="B35-tropicalmed-10-00043" ref-type="bibr">35</xref>,<xref rid="B36-tropicalmed-10-00043" ref-type="bibr">36</xref>]. Genotype D6 was associated with the Ukraine outbreak, while genotype D4 was detected in an outbreak in Romania. These two strains are highly related. In addition, the decreased diversity of the genotype D6 is detected as well as the rapid disappearance of the previously circulating C2 and D7 viruses. These observations lead to the conclusion that vaccination programmes had worked well and succeeded in the interruption of chains of transmission. However, at the same time, a concurrent process was taking place&#x02014;continuous reintroduction by importation and spread via the highly mobile European Region population, with measles viruses being continually imported from external sources. This results in a wobbling genotype landscape due to the number of susceptible individuals increasing and the transmission of the newly introduced viral genotypes. So on one hand, eradication programmes result in overall virus quenching, manifested infected cases with viruses with very limited genetic diversity and on the other hand possible rapid changes in the endemic genotypes [<xref rid="B27-tropicalmed-10-00043" ref-type="bibr">27</xref>,<xref rid="B37-tropicalmed-10-00043" ref-type="bibr">37</xref>,<xref rid="B38-tropicalmed-10-00043" ref-type="bibr">38</xref>,<xref rid="B39-tropicalmed-10-00043" ref-type="bibr">39</xref>,<xref rid="B40-tropicalmed-10-00043" ref-type="bibr">40</xref>]. Nevertheless, it is important to point out that no meaningful biological differences were detected among measles viruses of various genotypes&#x02014;neither in clinical symptoms nor in post-infection complications. Thus, genetic differentiation is an important tool for the monitoring of outbreaks and virus transmissions as well as for molecular epidemiology studies [<xref rid="B35-tropicalmed-10-00043" ref-type="bibr">35</xref>,<xref rid="B36-tropicalmed-10-00043" ref-type="bibr">36</xref>]. Thus, measles virus regional tracking is possible, exemplified by studies of transfer between Ukraine and Poland. Even though both countries share long boundaries and substantial travelling occurring between these countries, only a very limited increase in measles cases in Poland occurred&#x02014;120 confirmed infections as compared to 13 in 2005, which indicates the presence of a very effective measles control system operating in Poland [<xref rid="B28-tropicalmed-10-00043" ref-type="bibr">28</xref>]. Nevertheless, the following years showed that the control system was not ideal, as there was a relatively low number of suspected cases, which indicates an insufficient system of reporting all suspected symptoms. Since the maximum of measles infections in 2006, the number of observed cases was gradually declining until 2010. Then, a constant growth of reported cases was observed until 2014, reaching a relatively high level, similar to the one in 2006 [<xref rid="B20-tropicalmed-10-00043" ref-type="bibr">20</xref>,<xref rid="B30-tropicalmed-10-00043" ref-type="bibr">30</xref>].</p></sec><sec id="sec3dot3-tropicalmed-10-00043"><title>3.3. Poland: Social and Local Populations Factors</title><p>Since there were no measles epidemics in any nearby countries, it is highly probable that other factors had become dominant, such as anti-vaccination social movements. Even though the paper from 1998 by Lancet [<xref rid="B7-tropicalmed-10-00043" ref-type="bibr">7</xref>] was dismissed and numerous detailed studies, including those in Poland, show no connection between MMR vaccinations and autism, as well as other complications, the turmoil caused by this publication is still deeply rooted in societies [<xref rid="B6-tropicalmed-10-00043" ref-type="bibr">6</xref>]. This has caused the vaccination rate to decrease as a result of a number of parents&#x02019; decisions not to vaccinate children, the phenomenon is also clearly observed in Poland. As an apparent consequence, measles infections and local outbreaks are steadily increasing [<xref rid="B18-tropicalmed-10-00043" ref-type="bibr">18</xref>,<xref rid="B30-tropicalmed-10-00043" ref-type="bibr">30</xref>,<xref rid="B40-tropicalmed-10-00043" ref-type="bibr">40</xref>]. It has been shown that measles cases are underreported in areas occupied by ethnic minorities such as the Romani people and there are more frequently observed local outbreaks in their communities. Thus, it is desirable to increase the control system&#x02019;s effectiveness, especially in territories populated by minorities [<xref rid="B16-tropicalmed-10-00043" ref-type="bibr">16</xref>]. After analysing the degree of vaccinations among children and young people in Poland, it is evident that it is very high, with the first MMR dose (<xref rid="tropicalmed-10-00043-t003" ref-type="table">Table 3</xref>) [<xref rid="B20-tropicalmed-10-00043" ref-type="bibr">20</xref>]; however, the following years show a decline in the vaccination level. The dominant fraction of infected people comprises those who have not been vaccinated, for whom the vaccination status is unknown or who have received a single MMR dose only.</p></sec><sec id="sec3dot4-tropicalmed-10-00043"><title>3.4. Other European Region Countries</title><p>Statistical data derived from foreign publications and WHO reports for 53 countries of the region are analysed below. These include: (i) Western European Sub region: Andorra, Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Island, Ireland, Israel, Italy, Luxemburg, Malta, Monaco, Holland, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, and United Kingdom; (ii) Central and Eastern European Sub region: Albania, Bosnia-Herzegovina, Bulgaria, Croatia, Czechs, Estonia, Hungary, Lithuania, Latvia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, Macedonia, and Turkey; (iii) Sub region of ex-Soviet Union Countries: Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Russian Federation, Ukraine, Moldovia, Kirgizstan, Tajikistan, Uzbekistan, and Turkmenistan [<xref rid="B41-tropicalmed-10-00043" ref-type="bibr">41</xref>]. Measles and measles-related cases are shown in <xref rid="tropicalmed-10-00043-t003" ref-type="table">Table 3</xref> and <xref rid="tropicalmed-10-00043-t004" ref-type="table">Table 4</xref> and <xref rid="tropicalmed-10-00043-f003" ref-type="fig">Figure 3</xref> and <xref rid="tropicalmed-10-00043-f004" ref-type="fig">Figure 4</xref> based on the compiled data from the literature [<xref rid="B11-tropicalmed-10-00043" ref-type="bibr">11</xref>,<xref rid="B30-tropicalmed-10-00043" ref-type="bibr">30</xref>,<xref rid="B41-tropicalmed-10-00043" ref-type="bibr">41</xref>,<xref rid="B42-tropicalmed-10-00043" ref-type="bibr">42</xref>,<xref rid="B43-tropicalmed-10-00043" ref-type="bibr">43</xref>,<xref rid="B44-tropicalmed-10-00043" ref-type="bibr">44</xref>,<xref rid="B45-tropicalmed-10-00043" ref-type="bibr">45</xref>].</p><p>Measles is a disease which is required to be strictly reported in all 53 countries of the European Region and the data obtained in each country is submitted in the form of yearly reports to the WHO database. All these countries are encouraged to prepare and submit to WHO additional information, such as the age of infected people, their vaccination status, laboratory confirmations of measles cases and detected viral genotypes, among others. Despite continued inquiries, currently, only a limited number of the European Region countries send such extended monthly reports [<xref rid="B11-tropicalmed-10-00043" ref-type="bibr">11</xref>]. According to the WHO Programme regulations, since 2001 efforts have been made to maintain a high percentage of population vaccination, reaching in many countries of the region as much as 95% [<xref rid="B11-tropicalmed-10-00043" ref-type="bibr">11</xref>]. After analysing available data, it is evident that during the years 2007&#x02013;2009, a noticeable decline of measles cases in the European Region was observed, after ceasing the Ukrainian epidemic. Nevertheless, since 2010, the number of measles cases has been on the rise. The highest number of reported cases was noted in France and Spain. It was determined that this was mainly due to local outbreaks within ethnic groups of immigrants who had limited access to national healthcare programmes. Among them were those whose religious or other beliefs prevented them from undergoing vaccinations and people afraid of post-vaccination complications [<xref rid="B41-tropicalmed-10-00043" ref-type="bibr">41</xref>]. This trend, which started in 2010, is still observed, with reported measles cases systematically on the rise or stabilised on a relatively high level, as compared to previous years. Somewhat surprisingly and increasingly problematic is the fact that this negative scenario is linked to people refusing vaccinations in the most highly developed countries. This is in part a result of anti-vaccination social movements, which lead to lowering the number of vaccinated children and thus generating permissive targets for the virus. This phenomenon primarily concerns developed European countries, where a liberal approach to vaccinations is most pronounced. Even though Poland is not yet in this group, the same negative scenario is observed: for example, the vaccination rate indicating the first MMR dose in 2012 was 99.6%, in 2013&#x02014;99.5%, and in 2014&#x02014;98.5% [<xref rid="B46-tropicalmed-10-00043" ref-type="bibr">46</xref>]. Although a high vaccination percentage of 95% is reported, the trend shows a progressing decline. Overall, the situation is complicated by recent numerous wars outside the European Region, with the NATO army involved. Due to the expected high exposure to various infectious diseases, including measles, and inherently compromised sanitary standards during military operations, it is certainly difficult, if not locally impossible, to maintain conditions recommended by WHO and imposed by the Measles Eradication Programme. Another consequence of military operations is that vaccination programmes, as well as measles reporting systems, are operating partially or not operating at all in affected areas. Further complications, especially evident since 2015, include the uncontrolled migration of hundreds of thousands to millions of people from war-affected areas in Northern Africa, the Middle East and Ukraine to the European Region, which results in an inflow of a population with a high percentage of formally unknown vaccination status, but in reality&#x02014;unvaccinated.</p></sec></sec><sec sec-type="conclusions" id="sec4-tropicalmed-10-00043"><title>4. Conclusions</title><list list-type="order"><list-item><p>Despite the long history of measles vaccination programmes aiming at the elimination of epidemics and eradication of the measles virus, the analysis of the available data clearly shows that infection cases are on the rise in the European Region or are steady at a relatively high level, depending on the country.</p></list-item><list-item><p>Regardless of the reason, the decrease in the percentage of vaccinations leads to the formation of a measles-sensitive fraction of the population, not limited to children, but concerning all age groups.</p></list-item><list-item><p>The evident rise in measles infections in developed Western European countries, leading to local outbreaks, is troubling.</p></list-item><list-item><p>The necessary condition for measles eradication is strict adherence to the WHO Measles Eradication Programme for the European Region, which aims at infection eradication during 2012&#x02013;2020 [<xref rid="B47-tropicalmed-10-00043" ref-type="bibr">47</xref>].</p></list-item><list-item><p>Besides maintaining a vaccination level at a minimum of 95% using two doses of MMR, the critical factors seem to be adequate infection detection, rapid reporting, controlling and enforcing identification, and mass media campaigns to inform societies about the necessity of measles vaccination and safety of using MMR.</p></list-item></list></sec><sec id="sec5-tropicalmed-10-00043"><title>5. Paper Context</title><p>The vaccinations after the Second World War were expected to eliminate infectious diseases. However, epidemiological indexes show local epidemiology outbreaks of measles. Data concerning Poland were scattered in governmental reports in Polish only. The analysis shows that infection cases of measles are on the rise in Poland and in other parts of the European Region. The eradication programme modifications are needed, as measles is one of the most infectious diseases with acute syndromes, especially affecting children.</p></sec></body><back><ack><title>Acknowledgments</title><p>Jakub Zaleski is appreciated for English corrections. Bart&#x00142;omiej &#x00141;ubkowski is appreciated for the figure graphics improvement.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-tropicalmed-10-00043"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/tropicalmed10020043/s1">https://www.mdpi.com/article/10.3390/tropicalmed10020043/s1</uri>, Figure S1: Compilation of confirmed measles infections in Poland during the years 2003&#x02013;2014; Figure S2. incidences in Poland during the years 2003&#x02013;2014. The graph shows suspected and confirmed measles cases shown in relation to vaccination characteristics.; Figure S3. Reported measles cases in the European Region during the years 2003&#x02013;2014.</p><supplementary-material id="tropicalmed-10-00043-s001" position="float" content-type="local-data"><media xlink:href="tropicalmed-10-00043-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, D.M.; methodology, D.M.; resources, D.M., B.&#x00141;., J.J.-F. and P.M.S.; writing&#x02014;original draft preparation D.M. and P.M.S.; writing&#x02014;review and editing, B.&#x00141;. and J.J.-F.; supervision P.M.S.; project administration, B.&#x00141;. and P.M.S.; funding acquisition, P.M.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="app1-tropicalmed-10-00043" ref-type="app">Supplementary Materials</xref>. Further inquiries can be directed to the corresponding author(s).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-tropicalmed-10-00043"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barquet</surname><given-names>N.</given-names></name>
<name><surname>Domingo</surname><given-names>P.</given-names></name>
</person-group><article-title>Smallpox: The Triumph over the Most Terrible of the Ministers of Death</article-title><source>Ann. Intern. Med.</source><year>1997</year><volume>127</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-127-8_Part_1-199710150-00010</pub-id><pub-id pub-id-type="pmid">9341063</pub-id>
</element-citation></ref><ref id="B2-tropicalmed-10-00043"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kumaran</surname><given-names>S.</given-names></name>
<name><surname>Deivasigamani</surname><given-names>B.</given-names></name>
<name><surname>Alagappan</surname><given-names>K.M.</given-names></name>
<name><surname>Sakthivel</surname><given-names>M.</given-names></name>
</person-group><article-title>Infection and immunization trials of Asian seabass (<italic toggle="yes">Lates calcarifer</italic>) against fish pathogen <italic toggle="yes">Vibrio anguillarum</italic></article-title><source>J. Environ.Biol.</source><year>2010</year><volume>31</volume><fpage>539</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">21186732</pub-id>
</element-citation></ref><ref id="B3-tropicalmed-10-00043"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ha</surname><given-names>Y.M.</given-names></name>
<name><surname>Kim</surname><given-names>Y.I.</given-names></name>
<name><surname>Kim</surname><given-names>K.H.</given-names></name>
<name><surname>Kim</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Neutralization of white spot syndrome virus (WSSV) for Penaeus chinensis by antiserum raised against recombinant VP19</article-title><source>J. Environ. Biol.</source><year>2008</year><volume>29</volume><fpage>513</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">19195390</pub-id>
</element-citation></ref><ref id="B4-tropicalmed-10-00043"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mak&#x000f3;wka</surname><given-names>A.</given-names></name>
<name><surname>Gut</surname><given-names>W.</given-names></name>
<name><surname>Litwi&#x00144;ska</surname><given-names>B.</given-names></name>
</person-group><article-title>Podstawy programu eliminacji odry na &#x0015b;wiecie i w Polsce [Measles elimination programme on the world and Poland]</article-title><source>Przegl&#x00105;d Epidemiologiczny [Epidemiol. Rev.].</source><year>2007</year><volume>61</volume><fpage>135</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">17702452</pub-id>
</element-citation></ref><ref id="B5-tropicalmed-10-00043"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Dziubek</surname><given-names>Z.</given-names></name>
</person-group><source>Choroby Zaka&#x0017a;ne i Paso&#x0017c;ytnicze [Infectious and Parasitic Diseases]</source><publisher-name>PZWL</publisher-name><publisher-loc>Warszawa, Poland</publisher-loc><year>2010</year><fpage>275</fpage><lpage>279</lpage></element-citation></ref><ref id="B6-tropicalmed-10-00043"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mrozek-Budzy&#x00144;</surname><given-names>D.</given-names></name>
<name><surname>Kie&#x00142;tyka</surname><given-names>A.</given-names></name>
<name><surname>Majewska</surname><given-names>R.</given-names></name>
</person-group><article-title>Brak zwi&#x00105;zku mi&#x00119;dzy szczepieniami skojarzon&#x00105; szczepionk&#x00105; przeciw odrze, &#x0015b;wince i r&#x000f3;&#x0017c;yczce (MMR) a wyst&#x00119;powaniem autyzmu u dzieci&#x02014;Wynik badania kliniczno-kontrolnego [Lack of association between MMR vaccination and the incidence of autism in children: A case-control study]</article-title><source>Przegl&#x00105;d Epidemiologiczny [Epidemiol. Rev.]</source><year>2009</year><volume>63</volume><fpage>107</fpage><lpage>112</lpage></element-citation></ref><ref id="B7-tropicalmed-10-00043"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dyer</surname><given-names>C.</given-names></name>
</person-group><article-title>Lancet retracts Wakefield&#x02019;s MMR paper</article-title><source>Br. Med. J.</source><year>2010</year><volume>340</volume><fpage>c696</fpage><pub-id pub-id-type="doi">10.1136/bmj.c696</pub-id><pub-id pub-id-type="pmid">20124366</pub-id>
</element-citation></ref><ref id="B8-tropicalmed-10-00043"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Magdzik</surname><given-names>W.</given-names></name>
<name><surname>Naruszewicz-Lesiuk</surname><given-names>D.</given-names></name>
<name><surname>Zieli&#x00144;ski</surname><given-names>A.</given-names></name>
</person-group><source>Choroby Zaka&#x0017a;ne i Paso&#x0017c;ytnicze&#x02014;Epidemiologia i Profilaktyka [Infectious and Parasitic Diseases&#x02014;Epidemiology and Prevention]</source><publisher-name>Alfa Medica Press</publisher-name><publisher-loc>Bielsko-Bia&#x00142;a, Poland</publisher-loc><year>2007</year><fpage>205</fpage><lpage>209</lpage></element-citation></ref><ref id="B9-tropicalmed-10-00043"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Cianciara</surname><given-names>J.</given-names></name>
<name><surname>Juszczyk</surname><given-names>J.</given-names></name>
</person-group><source>Choroby Zaka&#x0017a;ne i Paso&#x0017c;ytnicze [Infectious and Parasitic Diseases]</source><publisher-name>Czelej Press</publisher-name><publisher-loc>Lublin, Poland</publisher-loc><year>2012</year><fpage>723</fpage><lpage>726</lpage></element-citation></ref><ref id="B10-tropicalmed-10-00043"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Magdzik</surname><given-names>W.</given-names></name>
<name><surname>Naruszewicz-Lesiuk</surname><given-names>D.</given-names></name>
</person-group><source>Zaka&#x0017c;enia i Zara&#x0017c;enia Cz&#x00142;owieka. Epidemiologia, Zapobieganie i Zwalczanie [Human Infections and Infestations. Epidemiology, Prevention and Control]</source><publisher-name>PZWL</publisher-name><publisher-loc>Warszawa, Poland</publisher-loc><year>2001</year><fpage>263</fpage><lpage>270</lpage></element-citation></ref><ref id="B11-tropicalmed-10-00043"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>Centers for Disease Control and Prevention (CDC)</collab>
</person-group><article-title>Progress toward measles elimination--European Region, 2005&#x02013;2008</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>2009</year><volume>20</volume><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">19229166</pub-id>
</element-citation></ref><ref id="B12-tropicalmed-10-00043"><label>12.</label><element-citation publication-type="gov"><person-group person-group-type="author">
<collab>Ministry of Health, Republic of Poland</collab>
</person-group><article-title>Act of 18 August 2011 on Mandatory Vaccinations, 2011</article-title><comment>Available online: <ext-link xlink:href="https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20111821086" ext-link-type="uri">https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20111821086</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-30">(accessed on 30 January 2025)</date-in-citation></element-citation></ref><ref id="B13-tropicalmed-10-00043"><label>13.</label><element-citation publication-type="gov"><article-title>Communicate of Chief Sanitary Inspectorate of the State Sanitary Inspection (SSI) of 29th October 2012 r. on Mandatory Vaccinations for 2013, 2012, Dz.U.</article-title><year>2012</year><comment>Available online: <ext-link xlink:href="https://dziennikmz.mz.gov.pl/DUM_MZ/2012/78/akt.pdf" ext-link-type="uri">https://dziennikmz.mz.gov.pl/DUM_MZ/2012/78/akt.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-22">(accessed on 22 January 2025)</date-in-citation></element-citation></ref><ref id="B14-tropicalmed-10-00043"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janaszek</surname><given-names>W.</given-names></name>
<name><surname>Gut</surname><given-names>W.</given-names></name>
<name><surname>Gay</surname><given-names>N.J.</given-names></name>
</person-group><article-title>The epidemiology of measles in Poland: Prevalence of measles virus antibodies in the population</article-title><source>Epidemiol Infect.</source><year>2000</year><volume>125</volume><fpage>385</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1017/S0950268899004616</pub-id><pub-id pub-id-type="pmid">11117962</pub-id>
</element-citation></ref><ref id="B15-tropicalmed-10-00043"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Freestone</surname><given-names>D.S.</given-names></name>
<name><surname>Prydie</surname><given-names>J.</given-names></name>
<name><surname>Smith</surname><given-names>S.G.</given-names></name>
<name><surname>Laurence</surname><given-names>G.</given-names></name>
</person-group><article-title>Vaccination of adults with Wistar RA 27/3 rubella vaccine</article-title><source>J. Hyg.</source><year>1971</year><volume>69</volume><fpage>471</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1017/S0022172400021720</pub-id><pub-id pub-id-type="pmid">5285946</pub-id>
</element-citation></ref><ref id="B16-tropicalmed-10-00043"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karasek</surname><given-names>E.</given-names></name>
<name><surname>Paradowska-Stankiewicz</surname><given-names>I.</given-names></name>
</person-group><article-title>Measles in Poland in 2011</article-title><source>Przegl. Epidemiol.</source><year>2013</year><volume>67</volume><fpage>181</fpage><lpage>309</lpage><page-range>181&#x02013;184, 307&#x02013;309</page-range><comment>(In Polish &#x00026; English)</comment><pub-id pub-id-type="pmid">24040712</pub-id>
</element-citation></ref><ref id="B17-tropicalmed-10-00043"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karasek</surname><given-names>E.</given-names></name>
<name><surname>Rogalska</surname><given-names>J.</given-names></name>
<name><surname>Paradowska-Stankiewicz</surname><given-names>I.</given-names></name>
</person-group><article-title>Odra w Polsce w 2010 roku [Measles in Poland in 2010]</article-title><source>Przegl. Epidemiol.</source><year>2012</year><volume>66</volume><fpage>185</fpage><lpage>190</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">23101202</pub-id>
</element-citation></ref><ref id="B18-tropicalmed-10-00043"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Nickerson</surname><given-names>E.</given-names></name>
<name><surname>Simon</surname><given-names>K.</given-names></name>
</person-group><source>Choroby Zaka&#x0017a;ne</source><publisher-name>Elsevier Urban &#x00026; Partner</publisher-name><publisher-loc>Wroc&#x00142;aw, Poland</publisher-loc><year>2008</year><fpage>77</fpage><lpage>78</lpage></element-citation></ref><ref id="B19-tropicalmed-10-00043"><label>19.</label><element-citation publication-type="gov"><person-group person-group-type="author">
<collab>Ministry of Health, Republic of Poland</collab>
</person-group><article-title>Act of 5th December 2008 on the Prevention and Control of Infections and Infectious diseases in Humans. 2008, Dz.U. 2016, 1866</article-title><comment>Available online: <ext-link xlink:href="https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20160001866" ext-link-type="uri">https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20160001866</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-22">(accessed on 22 January 2025)</date-in-citation></element-citation></ref><ref id="B20-tropicalmed-10-00043"><label>20.</label><element-citation publication-type="gov"><person-group person-group-type="author">
<collab>National Institute of Hygiene (PZH)</collab>
</person-group><article-title>Definicje Przypadk&#x000f3;w Chor&#x000f3;b Zaka&#x0017a;nych na Potrzeby Nadzoru Epidemiologicznego. (Case Definitions of Infectious Diseases for Epidemiological Surveillance Purposes)</article-title><year>2014</year><fpage>41</fpage><comment>Available online: <ext-link xlink:href="http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL2_3.pdf" ext-link-type="uri">http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL2_3.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-22">(accessed on 22 January 2025)</date-in-citation></element-citation></ref><ref id="B21-tropicalmed-10-00043"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rogalska</surname><given-names>J.</given-names></name>
</person-group><article-title>Odra w Polsce w 2009 roku [Measles in Poland in 2009]</article-title><source>Przegl. Epidemiol.</source><year>2011</year><volume>65</volume><fpage>181</fpage><lpage>184</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">21913455</pub-id>
</element-citation></ref><ref id="B22-tropicalmed-10-00043"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rogalska</surname><given-names>J.</given-names></name>
</person-group><article-title>Odra w Polsce w 2008 roku [Measles in Poland in 2008]</article-title><source>Przegl. Epidemiol.</source><year>2010</year><volume>64</volume><fpage>159</fpage><lpage>162</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">20731213</pub-id>
</element-citation></ref><ref id="B23-tropicalmed-10-00043"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stefanoff</surname><given-names>P.</given-names></name>
<name><surname>Rogalska</surname><given-names>J.</given-names></name>
</person-group><article-title>Odra w Polsce w 2007 roku [Measles in Poland in 2007]</article-title><source>Przegl. Epidemiol.</source><year>2009</year><volume>63</volume><fpage>169</fpage><lpage>172</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">19799238</pub-id>
</element-citation></ref><ref id="B24-tropicalmed-10-00043"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stefanoff</surname><given-names>P.</given-names></name>
<name><surname>Czarkowski</surname><given-names>M.P.</given-names></name>
<name><surname>Kondej</surname><given-names>B.</given-names></name>
</person-group><article-title>Odra w 2005 roku [Measles in 2005]</article-title><source>Przegl. Epidemiol.</source><year>2007</year><volume>61</volume><fpage>189</fpage><lpage>193</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">17956030</pub-id>
</element-citation></ref><ref id="B25-tropicalmed-10-00043"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stefanoff</surname><given-names>P.</given-names></name>
<name><surname>Czarkowski</surname><given-names>M.P.</given-names></name>
<name><surname>Kondej</surname><given-names>B.</given-names></name>
</person-group><article-title>Odra w 2004 roku [Measles in 2004]</article-title><source>Przegl. Epidemiol.</source><year>2006</year><volume>60</volume><fpage>383</fpage><lpage>388</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">17249157</pub-id>
</element-citation></ref><ref id="B26-tropicalmed-10-00043"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stefanoff</surname><given-names>P.</given-names></name>
<name><surname>Czarkowski</surname><given-names>M.P.</given-names></name>
</person-group><article-title>Odra w 2003 roku [Measles in Poland in 2003]</article-title><source>Przegl. Epidemiol.</source><year>2005</year><volume>59</volume><fpage>201</fpage><lpage>207</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">16190521</pub-id>
</element-citation></ref><ref id="B27-tropicalmed-10-00043"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Santibanez</surname><given-names>S.</given-names></name>
<name><surname>Tischer</surname><given-names>A.</given-names></name>
<name><surname>Heider</surname><given-names>A.</given-names></name>
<name><surname>Siedler</surname><given-names>A.</given-names></name>
<name><surname>Hengel</surname><given-names>H.</given-names></name>
</person-group><article-title>Rapid replacement of endemic measles virus genotypes</article-title><source>J. Gen. Virol.</source><year>2002</year><volume>83</volume><fpage>2699</fpage><lpage>2708</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-83-11-2699</pub-id><pub-id pub-id-type="pmid">12388805</pub-id>
</element-citation></ref><ref id="B28-tropicalmed-10-00043"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stefanoff</surname><given-names>P.</given-names></name>
<name><surname>Czarkowski</surname><given-names>M.P.</given-names></name>
<name><surname>Kondej</surname><given-names>B.</given-names></name>
</person-group><article-title>Odra w 2006 roku [Measles in 2006]</article-title><source>Przegl. Epidemiol.</source><year>2008</year><volume>62</volume><fpage>219</fpage><lpage>224</lpage><comment>(In Polish)</comment><pub-id pub-id-type="pmid">18807460</pub-id>
</element-citation></ref><ref id="B29-tropicalmed-10-00043"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rogalska</surname><given-names>J.</given-names></name>
<name><surname>Karasek</surname><given-names>E.</given-names></name>
<name><surname>Paradowska-Stankiewicz</surname><given-names>I.</given-names></name>
</person-group><article-title>Odra w Polsce w 2012 roku [Measles in Poland in 2012]</article-title><source>Przegl. Epidemiol.</source><year>2014</year><volume>68</volume><fpage>187</fpage><lpage>316</lpage><page-range>187&#x02013;190, 313&#x02013;316</page-range><comment>(In Polish &#x00026; English)</comment><pub-id pub-id-type="pmid">25135496</pub-id>
</element-citation></ref><ref id="B30-tropicalmed-10-00043"><label>30.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>World Health Organization (WHO)</collab>
</person-group><article-title>Measles Reported Cases by Country</article-title><year>2015</year><comment>Available online: <ext-link xlink:href="http://apps.who.int/gho/data/view.main.1540_62?lang=en" ext-link-type="uri">http://apps.who.int/gho/data/view.main.1540_62?lang=en</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-30">(accessed on 30 January 2025)</date-in-citation></element-citation></ref><ref id="B31-tropicalmed-10-00043"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Satman</surname><given-names>I.</given-names></name>
<name><surname>Bayirlioglu</surname><given-names>S.</given-names></name>
<name><surname>Okumus</surname><given-names>F.</given-names></name>
<name><surname>Erturk</surname><given-names>N.</given-names></name>
<name><surname>Yemenici</surname><given-names>M.</given-names></name>
<name><surname>Cinemre</surname><given-names>S.</given-names></name>
<name><surname>Gulfidan</surname><given-names>G.</given-names></name>
<name><surname>Arga</surname><given-names>K.Y.</given-names></name>
</person-group><article-title>Estimates and forecasts on the burden of prediabetes and diabetes in adult and elderly population in Turkiy</article-title><source>Eur. J. Epidemiol.</source><year>2023</year><volume>38</volume><fpage>313</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1007/s10654-022-00960-8</pub-id><pub-id pub-id-type="pmid">36696072</pub-id>
</element-citation></ref><ref id="B32-tropicalmed-10-00043"><label>32.</label><element-citation publication-type="gov"><article-title>How Has the Measles Vaccine Been Used in the Past?</article-title><comment>Available online: <ext-link xlink:href="https://szczepienia.pzh.gov.pl/faq/jak-szczepionka-przeciw-odrze-byla-stosowana-w-przeszlosci/" ext-link-type="uri">https://szczepienia.pzh.gov.pl/faq/jak-szczepionka-przeciw-odrze-byla-stosowana-w-przeszlosci/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-24">(accessed on 24 January 2025)</date-in-citation></element-citation></ref><ref id="B33-tropicalmed-10-00043"><label>33.</label><element-citation publication-type="gov"><article-title>Historical Immunization Programs</article-title><comment>Available online: <ext-link xlink:href="https://szczepienia.pzh.gov.pl/kalendarz-szczepien/" ext-link-type="uri">https://szczepienia.pzh.gov.pl/kalendarz-szczepien/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-24">(accessed on 24 January 2025)</date-in-citation></element-citation></ref><ref id="B34-tropicalmed-10-00043"><label>34.</label><element-citation publication-type="gov"><article-title>Population Structure by Age in the Years 1970&#x02013;2060</article-title><comment>Available online: <ext-link xlink:href="https://stat.gov.pl/obszary-tematyczne/ludnosc/ludnosc/struktura-ludnosci,16,1.html" ext-link-type="uri">https://stat.gov.pl/obszary-tematyczne/ludnosc/ludnosc/struktura-ludnosci,16,1.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-24">(accessed on 24 January 2025)</date-in-citation></element-citation></ref><ref id="B35-tropicalmed-10-00043"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cz&#x00119;&#x0015b;cik</surname><given-names>A.</given-names></name>
<name><surname>Trzci&#x00144;ska</surname><given-names>A.</given-names></name>
<name><surname>Siennicka</surname><given-names>J.</given-names></name>
</person-group><article-title>Wirus odry&#x02014;Reakcje odporno&#x0015b;ciowe zwi&#x00105;zane z naturalnym zaka&#x0017c;eniem oraz odpowiedzi&#x00105; poszczepienn&#x00105; [The measles virus&#x02014;Immunologic reactions connected with natural infection and vaccination response]</article-title><source>Adv. Microbiol.</source><year>2011</year><volume>50</volume><fpage>235</fpage><lpage>245</lpage></element-citation></ref><ref id="B36-tropicalmed-10-00043"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rota</surname><given-names>P.A.</given-names></name>
<name><surname>Featherstone</surname><given-names>D.A.</given-names></name>
<name><surname>Bellini</surname><given-names>W.J.</given-names></name>
</person-group><article-title>Molecular epidemiology of measles virus</article-title><source>Curr. Top. Microbiol.</source><year>2009</year><volume>330</volume><fpage>129</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1007/978-3-540-70617-5_7</pub-id><pub-id pub-id-type="pmid">19203108</pub-id>
</element-citation></ref><ref id="B37-tropicalmed-10-00043"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kremer</surname><given-names>J.R.</given-names></name>
<name><surname>Brown</surname><given-names>K.E.</given-names></name>
<name><surname>Jin</surname><given-names>L.</given-names></name>
<name><surname>Santibanez</surname><given-names>S.</given-names></name>
<name><surname>Shulga</surname><given-names>S.V.</given-names></name>
<name><surname>Aboudy</surname><given-names>Y.</given-names></name>
<name><surname>Demchyshyna</surname><given-names>I.V.</given-names></name>
<name><surname>Djemileva</surname><given-names>S.</given-names></name>
<name><surname>Echevarria</surname><given-names>J.E.</given-names></name>
<name><surname>Featherstone</surname><given-names>D.F.</given-names></name>
<etal/>
</person-group><article-title>High genetic diversity of measles virus, World Health Organization European Region, 2005&#x02013;2006</article-title><source>Emerg. Infect. Dis.</source><year>2008</year><volume>14</volume><fpage>107</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.3201/eid1401.070778</pub-id><pub-id pub-id-type="pmid">18258089</pub-id>
</element-citation></ref><ref id="B38-tropicalmed-10-00043"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mulders</surname><given-names>M.N.</given-names></name>
<name><surname>Nebie</surname><given-names>Y.K.</given-names></name>
<name><surname>Fack</surname><given-names>F.</given-names></name>
<name><surname>Kapitanyuk</surname><given-names>T.</given-names></name>
<name><surname>Sanou</surname><given-names>O.</given-names></name>
<name><surname>Val&#x000e9;a</surname><given-names>D.C.</given-names></name>
<name><surname>Muyembe-Tamfum</surname><given-names>J.J.</given-names></name>
<name><surname>Ammerlaan</surname><given-names>W.</given-names></name>
<name><surname>Muller</surname><given-names>C.P.</given-names></name>
</person-group><article-title>Limited diversity of measles field isolates after a national immunization day in Burkina Faso: Progress from endemic to epidemic transmission?</article-title><source>J. Infect. Dis.</source><year>2003</year><volume>187</volume><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1086/368036</pub-id><pub-id pub-id-type="pmid">12721926</pub-id>
</element-citation></ref><ref id="B39-tropicalmed-10-00043"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rima</surname><given-names>B.K.</given-names></name>
<name><surname>Earle</surname><given-names>J.A.</given-names></name>
<name><surname>Yeo</surname><given-names>R.P.</given-names></name>
<name><surname>Herlihy</surname><given-names>L.</given-names></name>
<name><surname>Baczko</surname><given-names>K.</given-names></name>
<name><surname>Ter Meulen</surname><given-names>V.</given-names></name>
<name><surname>Carabana</surname><given-names>J.</given-names></name>
<name><surname>Caballero</surname><given-names>M.</given-names></name>
<name><surname>Celma</surname><given-names>M.L.</given-names></name>
<name><surname>Fernandez-Munoz</surname><given-names>R.</given-names></name>
</person-group><article-title>Temporal and geographical distribution of measles virus genotypes</article-title><source>J. Gen. Virol.</source><year>1995</year><volume>76</volume><fpage>1173</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-76-5-1173</pub-id><pub-id pub-id-type="pmid">7730801</pub-id>
</element-citation></ref><ref id="B40-tropicalmed-10-00043"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rogalska</surname><given-names>J.</given-names></name>
</person-group><article-title>Measles in Poland in 2013</article-title><source>Przegl. Epidemiol.</source><year>2015</year><volume>69</volume><fpage>205</fpage><lpage>338</lpage><page-range>205&#x02013;207, 335&#x02013;338</page-range><comment>Erratum in <italic toggle="yes">Przegl. Epidemiol.</italic>
<bold>2015</bold>, <italic toggle="yes">69</italic>, 452, 478. (In Polish &#x00026; English)</comment><pub-id pub-id-type="pmid">26233072</pub-id>
</element-citation></ref><ref id="B41-tropicalmed-10-00043"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>Centers for Disease Control and Prevention (CDC)</collab>
</person-group><article-title>Increased Transmission and Outbreaks of Measles&#x02014;European Region 2011</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>2011</year><volume>60</volume><fpage>1605</fpage><lpage>1610</lpage><pub-id pub-id-type="pmid">22129994</pub-id>
</element-citation></ref><ref id="B42-tropicalmed-10-00043"><label>42.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>World Health Organization (WHO)</collab>
</person-group><article-title>Reported Measles Cases and Incidence Rates by WHO Member States 2013, 2014 as of 11 February 2015</article-title><year>2016</year><comment>Available online: <ext-link xlink:href="https://immunizationdata.who.int/global/wiise-detail-page/measles-reported-cases-and-incidence?CODE=Global&#x00026;YEAR=" ext-link-type="uri">https://immunizationdata.who.int/global/wiise-detail-page/measles-reported-cases-and-incidence?CODE=Global&#x00026;YEAR=</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-30">(accessed on 30 January 2025)</date-in-citation></element-citation></ref><ref id="B43-tropicalmed-10-00043"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martin</surname><given-names>R.</given-names></name>
<name><surname>Wassilak</surname><given-names>S.</given-names></name>
<name><surname>Emiroglu</surname><given-names>N.</given-names></name>
<name><surname>Uzicanin</surname><given-names>A.</given-names></name>
<name><surname>Deshesvoi</surname><given-names>S.</given-names></name>
<name><surname>Jankovic</surname><given-names>D.</given-names></name>
<name><surname>Goel</surname><given-names>A.</given-names></name>
<name><surname>Khetsuriani</surname><given-names>N.</given-names></name>
</person-group><article-title>What Will It Take to Achieve Measles Elimination in the World Health Organization European Region: Progress From 2003&#x02013;2009 and Essential Accelerated Actions</article-title><source>J. Infect. Dis.</source><year>2011</year><volume>204</volume><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir137</pub-id></element-citation></ref><ref id="B44-tropicalmed-10-00043"><label>44.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>World Health Organization (WHO)</collab>
</person-group><article-title>Status Report on Progress Towards Measles and Rubella Elimination SAGE Working Group on Measles and Rubella (22 October 2012)</article-title><comment>Available online: <ext-link xlink:href="https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_Nov2012/7_session_measles-rubella/Nov2012_session7_progress_measles-rubella_elimination.pdf" ext-link-type="uri">https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_Nov2012/7_session_measles-rubella/Nov2012_session7_progress_measles-rubella_elimination.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-24">(accessed on 24 January 2025)</date-in-citation></element-citation></ref><ref id="B45-tropicalmed-10-00043"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Connor</surname><given-names>P.</given-names></name>
<name><surname>Jankovic</surname><given-names>D.</given-names></name>
<name><surname>Muscat</surname><given-names>M.</given-names></name>
<name><surname>Ben-Mamou</surname><given-names>M.</given-names></name>
<name><surname>Reef</surname><given-names>S.</given-names></name>
<name><surname>Papania</surname><given-names>M.</given-names></name>
<name><surname>Singh</surname><given-names>S.</given-names></name>
<name><surname>Kaloumenos</surname><given-names>T.</given-names></name>
<name><surname>Butler</surname><given-names>R.</given-names></name>
<name><surname>Datta</surname><given-names>S.</given-names></name>
</person-group><article-title>Measles and rubella elimination in the WHO Region for Europe: Progress and challenges</article-title><source>Clin. Microbiol. Infect.</source><year>2017</year><volume>23</volume><fpage>504</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2017.01.003</pub-id><pub-id pub-id-type="pmid">28111293</pub-id>
</element-citation></ref><ref id="B46-tropicalmed-10-00043"><label>46.</label><element-citation publication-type="gov"><person-group person-group-type="author">
<collab>The National Institute of Public Health&#x02014;National Institute of Hygiene in Poland (NIPH&#x02013;NIH)</collab>
</person-group><article-title>&#x0201c;Vaccinations in Poland&#x0201d; (Annual Report)</article-title><year>2016</year><comment>Available online: <ext-link xlink:href="http://wwwold.pzh.gov.pl/oldpage/epimeld/index_a.html#05" ext-link-type="uri">http://wwwold.pzh.gov.pl/oldpage/epimeld/index_a.html#05</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-24">(accessed on 24 January 2025)</date-in-citation></element-citation></ref><ref id="B47-tropicalmed-10-00043"><label>47.</label><element-citation publication-type="webpage"><article-title>WHO Global Measles and Rubella Strategic Plan 2012&#x02013;2020</article-title><comment>Available online: <ext-link xlink:href="https://iris.who.int/bitstream/handle/10665/44855/9789241503396_eng.pdf" ext-link-type="uri">https://iris.who.int/bitstream/handle/10665/44855/9789241503396_eng.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-24">(accessed on 24 January 2025)</date-in-citation></element-citation></ref></ref-list></back><floats-group><fig position="float" id="tropicalmed-10-00043-f001"><label>Figure 1</label><caption><p>Compilation of confirmed measles infections in Poland during the years 2003&#x02013;2014 (<xref rid="app1-tropicalmed-10-00043" ref-type="app">Figures S1 and S2</xref>).</p></caption><graphic xlink:href="tropicalmed-10-00043-g001" position="float"/></fig><fig position="float" id="tropicalmed-10-00043-f002"><label>Figure 2</label><caption><p>Compilation of total measles-related disease cases with symptoms, which are or can be connected with measles infection incidences in Poland during the years 2003&#x02013;2014. The graph shows suspected and confirmed measles cases shown in relation to vaccination characteristics (<xref rid="app1-tropicalmed-10-00043" ref-type="app">Figures S1 and S2</xref>).</p></caption><graphic xlink:href="tropicalmed-10-00043-g002" position="float"/></fig><fig position="float" id="tropicalmed-10-00043-f003"><label>Figure 3</label><caption><p>Reported measles cases in the European Region during the years 2003&#x02013;2014 <xref rid="app1-tropicalmed-10-00043" ref-type="app">Figure S3</xref>.</p></caption><graphic xlink:href="tropicalmed-10-00043-g003" position="float"/></fig><fig position="float" id="tropicalmed-10-00043-f004"><label>Figure 4</label><caption><p>European Region countries with the highest numbers of measles cases reported during the years 2003&#x02013;2014 <xref rid="app1-tropicalmed-10-00043" ref-type="app">Figure S3</xref>.</p></caption><graphic xlink:href="tropicalmed-10-00043-g004" position="float"/></fig><table-wrap position="float" id="tropicalmed-10-00043-t001"><object-id pub-id-type="pii">tropicalmed-10-00043-t001_Table 1</object-id><label>Table 1</label><caption><p>Measles cases in Poland during the years 2003&#x02013;2014. The number of infections and death cases as well as infections and death cases per 100,000 people (<xref rid="app1-tropicalmed-10-00043" ref-type="app">Figures S1 and S2</xref>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2003</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2004</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2005</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2006</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2007</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2008</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2009</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2010</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2011</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2012</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2013</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2014</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The number of measles cases in Poland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">115</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">110</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Population size</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,190</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,173</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,157</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,125</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,115</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,135</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,167</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,529</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,538</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,533</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,495</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38,478</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Number of cases per 100,000 people</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.126</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.029</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.034</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.315</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.105</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.262</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.301</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.034</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.099</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.182</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.218</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.286</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00043-t002"><object-id pub-id-type="pii">tropicalmed-10-00043-t002_Table 2</object-id><label>Table 2</label><caption><p>Suspected and confirmed measles cases in Poland during the years 2003&#x02013;2014, profiled to vaccination characteristics and schemes, vaccinated child&#x02019;s age, and nationality.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2003</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2004</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2005</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2006</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2007</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2008</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2009</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2010</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2011</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2012</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2013</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2014</th></tr></thead><tbody><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Status measles cases in Poland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suspected</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">289</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">152</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">177</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">147</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">258</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">182</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">115</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">110</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unvaccinated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 dose</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00043-t003"><object-id pub-id-type="pii">tropicalmed-10-00043-t003_Table 3</object-id><label>Table 3</label><caption><p>Reported measles cases in the European Region during the years 2003&#x02013;2014.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2003</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2004</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2005</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2006</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2007</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2008</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2009</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2010</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2011</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2012</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2013</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2014</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The number of measles cases in WHO European Region</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28,203</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29,510</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37,338</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53,344</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6936</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8879</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7499</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30,625</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37,101</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37,101</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26,436</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14,059</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tropicalmed-10-00043-t004"><object-id pub-id-type="pii">tropicalmed-10-00043-t004_Table 4</object-id><label>Table 4</label><caption><p>European Region countries with the highest numbers of measles cases reported during the years 2003&#x02013;2014 <xref rid="app1-tropicalmed-10-00043" ref-type="app">Figure S3</xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2009</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2010</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2011</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2012</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2013</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2014</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total Number of Measles Cases in Countries<break/>2009&#x02013;2014</th></tr></thead><tbody><tr><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Countries in the WHO European Region</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bosnia and Herzegovina</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2204</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2308</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">France</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1541</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15,214</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">754</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">272</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">267</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23,067</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Georgia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7868</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3190</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11,198</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ukraine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1313</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11,086</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3308</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2326</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18,099</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Romania</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">187</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4417</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2447</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1159</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8271</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">173</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">861</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5179</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">530</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2251</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1676</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10,670</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spain </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">285</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3507</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">401</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">131</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">153</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4520</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">United Kingdom</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1176</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">397</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1083</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1093</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1900</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5786</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">572</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">805</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">139</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1781</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">436</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5333</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Russian Federation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">101</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">152</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">783</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1771</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2500</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3248</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8555</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WHO European Region</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7499</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30,625</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37,101</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27,379</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26,436</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14,059</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">143,099</td></tr></tbody></table></table-wrap></floats-group></article>